Most institutional brokerage firms and equity analysts maintain cautious or neutral stances on SGR rather than outright buy recommendations, citing high execution risks associated with its ongoing corporate turnaround and regulatory negotiations. What are your primary financial return objectives, total available investment budget, and risk parameters? Professional financial guidance is advised before trading.